iNtRON Biotechnology Inc

048530

Company Profile

  • Business description

    iNtRON Biotechnology Inc is a Korea-based biotechnology firm focused on the research, development, and commercialization of biopharmaceuticals and molecular diagnostics. Its core business includes developing bacteriophage- and endolysin-based therapeutic platforms for infectious diseases, immune disorders, microbiome-related diseases, vaccines, and oncology applications. It also develops and manufactures PCR/qPCR-based molecular diagnostic kits for human and animal infectious diseases, supported by GMP-certified automated production facilities. In addition, the company pursues strategic partnerships and equity investments to expand its biotechnology ecosystem and commercialize technologies derived from its drug development programs.

  • Contact

    137 Sagimakgol-ro
    701-704, Jungang Induspia 5
    Jungwon-gu
    Gyeonggi-do
    Seongnam-si
    KOR

    T: +82 317395678

    http://www.intron.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    73

Stocks News & Analysis

stocks

Wide moat share expects luck to turn

A tough year for jackpots however earnings are expected to normalise.
stocks

ASX share’s growth story intact despite supply constraints

Short term supply challenges but Chinese growth story remains intact.
stocks

ASX healthcare giant rallies despite a fall in profits

Easing investor concerns and signalling a return to growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,269.7013.70-0.15%
CAC 408,462.068.970.11%
DAX 4026,060.9677.920.30%
Dow JONES (US)52,759.21703.84-1.32%
FTSE 10010,770.7422.580.21%
HKSE26,009.46310.971.21%
NASDAQ26,067.17263.92-1.00%
Nikkei 22566,016.36200.43-0.30%
NZX 50 Index13,972.6652.840.38%
S&P 5007,641.1666.82-0.87%
S&P/ASX 2009,058.906.90-0.08%
SSE Composite Index3,905.201.480.04%

Market Movers